Skip to content
Forensic Analysis · Software & SaaS · as of Nov 11, 2026

Intapp, Inc. (INTA)

A forensic read on Intapp, Inc. built from its complete SEC filings — financial-health screens, earnings quality, red flags and a price-aware rating. Reproducible math, not opinion.

D · Weak — demands caution
Forensic grade
Distress
Financial health
-3.9
Distress distance
Clean
Earnings quality
4
Forensic signals
-9.9%
ROE
14.6%
Revenue growth

This free snapshot doesn't read filing or proxy text, so the auditor-quality and governance checks that can lower a grade were not evaluated (auditor quality, say on pay, board independence, going concern). Those checks only ever lower a grade, so the full analysis can land below the grade above but never above it — treat it as the most favourable reading, not the settled one.

Intapp, Inc. earns a D (Weak — demands caution) forensic quality grade, and its balance-sheet distress test reads -3.9, placing it in the Distress zone. 4 forensic signals were flagged in its latest SEC filings, led by return on invested capital.

What the filings flag

-15.2%
FY2026
Return on invested capital. Return on invested capital is -15.2% in the latest fiscal year, against -11.4% in FY2024, having run between -15.2% and -9.5% across FY2024–FY2026 with no direction held. After-tax operating profit was ($25M) in FY2024 and ($32M) in FY2026, with operating income at -7.5% of revenue in FY2024, -5.4% in FY2025 and -6.9% in FY2026. The capital base behind it went from $224M in FY2024 to $208M in FY2026 (-7%), while the revenue it carried went from $431M to $578M. Across FY2025–FY2026, $71M went into capital expenditure and acquisitions against $13M of depreciation excluding $22M of intangible-asset amortisation. The base is struck net of amortisation, write-downs and the current liabilities that fund it, so it moved by less than that spending net of the wear, and this row does not say which of those absorbed the difference. FY2026's operating profit carried a $8M restructuring charge and a $3M asset write-down that alone took about 4.1 points off that year's return, so more than the whole 3.8-point fall across FY2024–FY2026 is that charge landing in the latest year rather than the capital earning less. A non-cash write-down lowers the reported return in the year it lands.
+5.5%/yr
FY2024–FY2026
Share-count dilution. Diluted share count changed +11% over the last 2 years to FY2026 (+5.5%/yr). The count is growing — 71.5M shares in FY2024, 79.6M in FY2026: more stock was issued than repurchased over this window, so aggregate results grew faster than their per-share equivalents. That's ~5.5% shaved off per-share growth every year — total profit has to grow that much just to keep earnings-per-share flat, and a stake held since FY2024 has been diluted ~10%.
202% of FCF
FY2026
Shareholder returns. Returned $275M to shareholders (buybacks + dividends) in FY2026 — 202% of free cash flow. That is $139M (102%) more than free cash flow covered, and more than operating cash flow as well. It came out of the balance sheet's own liquid holdings, not new debt: cash fell $150M over FY2026. A payout past free cash flow draws the balance sheet down in every year it continues, which isn't sustainable indefinitely. Counting the $120M of stock-based comp paid out in shares on top of that, the combined claim on free cash flow is 290%.
21% of rev
FY2026
Stock-based comp load. Stock-based compensation ran 21% of revenue and 88% of free cash flow in FY2026 — about $1.51 per diluted share. No cash left the business to pay it, which is why operating cash flow adds it back. Net of repurchases the diluted count still rose about 5.5% a year across FY2024–FY2026, and the rate is falling. Stock compensation is one source of that issuance; acquisition consideration, equity raises, convertibles and other employee plans also net into the count, and these figures do not separate them.

Key fundamentals

Latest Revenue$577.8M
Revenue Growth YoY+14.6%
Revenue CAGR (2yr)+15.8%
Net Margin-7.1%
Free Cash Flow$136.4M
Return on Equity-9.9%

The forensic grade and screens above are free — no account needed. Want the AI investment read on top — the 0–100 rating, thesis, bull-vs-bear, red flags and the 12-month scenario, written from Intapp, Inc.'s actual 10-K/10-Q/8-K filings?

Generate the AI investment read →

No credit card · informational only, not investment advice · see the track record

← Browse all forensic stock analyses

Data from SEC EDGAR public filings · metrics as of Nov 11, 2026. Forensic signals flag probability, not certainty.

See a wrong number? Report an error with the filing it should match.